Mahdi Rahaie

Mahdi Rahaie

Auto-generated profile, based on publicly available information

Mahdi Rahaie

Department of Nanobiotechnology and Biomimetics, School of Life Science Engineering, College of Interdisciplinary Science and Technology, University of Tehran, Tehran, Iran

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Mostafa AzimzadehMostafa Azimzadeh
Mostafa Azimzadeh
MRMahdi Rahaie
Mahdi Rahaie
NNNavid Nasirizadeh
Navid Nasirizadeh
KAKhadijeh Ashtari
Khadijeh Ashtari
HNHossein Naderi-Manesh
Hossein Naderi-Manesh

8 December 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
Mostafa AzimzadehMostafa Azimzadeh
Mostafa Azimzadeh
NNNavid Nasirizadeh
Navid Nasirizadeh
MRMahdi Rahaie
Mahdi Rahaie
HNHossein Naderi-Manesh
Hossein Naderi-Manesh
Alzheimer's disease (AD) is the most common form of dementia, and its early detection using reliable molecular biomarkers is believed to be best approach to controlling and even curing it. Herein, we develop an ultrasensitive electrochemical nanobiosensor to quantify serum miR-137 as a validated biomarker of AD. Electrochemically-reduced graphene oxide (ERGO) and gold nanowires (AuNWs) are used to modify the surface of a screen-printed carbon electrode (SPCE) with the application of an intercalated label, doxorubicin (Dox). The fabrication steps are analysed via field emission scanning electron microscopy (FE-SEM) and energy dispersive spectroscopy (EDS), as well as two reliable electrochemical methods, cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The results show that the linear range of the nanobiosensor is from 5.0 to 750.0 fM and its limit of detection is 1.7 fM. In addition, the nanobiosensor shows a great performance in specificity experiments and is able to discriminate between target oligos versus non-specific oligos (one-base mismatch target; three-base mismatch target, non-specific miR-21 and miR-155) very well. The evaluation of the sensing mechanism of the developed nanobiosensor in actual human serum reveals its potential clinical applications for the early detection of AD in the future.

1 September 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
FCFaraz Chogan
Faraz Chogan
TMTahereh Mirmajidi
Tahereh Mirmajidi
ARAli Hossein Rezayan
Ali Hossein Rezayan
ASAli mohammad Sharifi
Ali mohammad Sharifi
AGAziz Ghahary
Aziz Ghahary
MRMahdi Rahaie
Mahdi Rahaie

31 July 2012 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
MMMahnaz Mandeh
Mahnaz Mandeh
MOMansoor Omidi
Mansoor Omidi
MRMahdi Rahaie
Mahdi Rahaie

5 February 2020 in Journal of Nanostructure in Chemistry
Verified
Journal Article
Open access
PDF file
SNShilan Nasri
Shilan Nasri
BEBahman Ebrahimi-Hosseinzadeh
Bahman Ebrahimi-Hosseinzadeh
MRMahdi Rahaie
Mahdi Rahaie
AHAshrafalsadat Hatamian-Zarmi
Ashrafalsadat Hatamian-Zarmi
RSRazi Sahraeian
Razi Sahraeian
Ethosomes are most commonly used vesicular delivery system compared to other lipidic vesicles due to its ethanolic content. Thymoquinone (TQ), the main biologically active complex of Black Cumin seed, has established anticancer activities in several tumors. In this work, the preparation of ethosome for TQ encapsulation by response surface method (RSM) was developed. Central composite design (CCD) was used to optimize three effective parameters involved in ethosome structure including phospholipid, cholesterol and ethanol concentration and the combined effects of them, as well. The obtained optimum values for the variables were phospholipid 5% (W/W), ethanol 45% (V/V) and cholesterol 1.5% (W/W) which were validated by experimental assay. The ethosomal formulation was more characterized for vesicle shape, size, zeta potential and entrapment efficiency percentage. The result showed an efficiency of 99% for drug entrapment with average vesicle size and zeta potential of 20 ± 1 nm and − 63 ± 2 mv, respectively. A quadratic model with a high adequacy (R2) for size and zeta potential of 0.9319 and 0.9338, respectively, was resulted from RSM and experimental assay. Thymoquinone (TQ) encapsulated in optimized ethosome. Also, cellular toxicity and release test was done. The toxicity and release curves were obtained and the cytotoxic activity of the ethosomic TQ against MCF-7 cell lines was greater than free TQ. IC50 values of free TQ, ethosomic TQ, were found to be 1.10 µg/ml, 0.95 µg/ml, respectively. The generated model suggests a new approach to prediction and experimental lipidic carriers. Graphic Central composite design (CCD) was used to optimize three effective parameters involved in ethosome structure including phospholipid, cholesterol and ethanol concentration and the combined effects of them, as well. The ethosomal formulation was more characterized for vesicle shape, size, zeta potential and entrapment efficiency percentage. Also, cellular toxicity and release test was done. The toxicity and release curves were obtained and the cytotoxic activity of the ethosomic TQ against MCF-7 cell lines was greater than free TQ.